Nicotine enemas for active ulcerative colitis - A pilot study

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 5, 1997, Pages 859-863

  Green, J T ^a,f   Thomas, G A O ^a   Rhodes, J ^a   Williams, G T ^b   Evans, B K ^c   Russell, M A H ^d   Feyerabend, C ^e   Rhodes, P ^c   Sandborn, W J ^d  

^a Department Gastroenterology ^*  (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Temple of Health and Peace ^*  (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e MAYO CLINIC   (United States)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARBOPOL 974P; CYCLOSPORIN; ENEMA; MESALAZINE; NICOTINE; POLYACRYLIC ACID; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; RELAPSE; SIGMOIDOSCOPY; SYNCOPE; ULCERATIVE COLITIS; VERTIGO;

EID: 0030863302     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00220.x     Document Type: Article

References (19)

1. Harries AD, Baird A, Rhodes J. Non smoking: a feature of ulcerative colitis. Br Med J 1982; 284: 706.
2. Logan RFA, Edmond M, Somerville KW, Langman MJ. Smoking and ulcerative colitis. Br Med J 1984; 288: 751-3.
3. Motley RJ, Rhodes J, Kay S, Morris TJ. Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis 1988; 3: 171-5.
4. Motley RJ, Rhodes J, Ford GA, et al Time relationships betxveen cessation of smoking and onset of ulcerative colitis. Digestion 1987; 37: 125-7.
5. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sei 1989; 34: 1841-54.
6. Rudra T, Motley R, Rhodes J. Does smoking improve colitis? Scand J Gastroenterol 1989; 170 (Suppl.): 61-3.
7. De Castella H. Non smoking: a feature of ulcerative colitis. Br MedJ 1982:284: 1706.
8. Srivastava ED, Russell MAH, Feyerabend C, Williams GT, Masterson JG, Rhodes J. Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol 1991; 3: 815-8.
9. Pullan RD, Rhodes J, Ganesh S, et al Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811-5.
10. Sandborn W], Tremaine W, Offord KP, et al A randomised, double-blind, placebo-controlled trial of transdermal nicotine for mildly to moderately active ulcerative colitis. Ann Intern Med 1997; 126: 364-71.
11. Thomas GAO, Rhodes J, Mani V, et al Transdermal nicotine for maintenance therapy of ulcerative colitis. N Engl J Med 1995; 332: 988-92.
12. Benowitz NL, Jacob P, Denard C, Jenkins R. Stable isotope studies of nicotine, kinetics and bioavailability. Clin PharmacolTher 1991: 49: 270-7.
13. Green JT, Thomas GAO, Rhodes J, et al. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis. Clin Pharmacol Ther 1997; 61: 340-8.
14. Dick AP, Grayson MJ, Carpenter RG, Pétrie A. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 1964: 5: 437-42.
15. Lennard-Jones JE. Classification of Inflammatory Bowel Disease. Scand J Gastroenterol 1989; 24 (Suppl. 170): 2-6.
16. Carbomer. Monograph in The British Pharmacopoeia, published by HMSO London on behalf of The British Pharmacopoeial Commission 1993; Vol 1: 112-3.
17. Truelove SC, Richards WCD. Biopsy studies in ulccrative colitis. Br Med J 1956; 1: 1315-21.
18. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, LennardJones ]E. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sei 1982; 27: 533-7.
19. Zins BJ, Sandborn WJ, Mays D, et al. A study of nicotine pharmacokinetics following single dose IV, oral and enema administration. Gastroenterology 1996; 110 (4): 1054 (Abstract).